Discover the latest buzz in biotech! Absci WSJ Tech Live 2022 shines a spotlight on the intersection of biology and AI, hinting at a potential stock breakout. With Nasdaq's biotech spotlight shining on Absci Corp, Cramer predicts this stock could be worth billions on FDA approval. Stay tuned for insights on this emerging biotech leader!